Cited by 478Cardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmiasCardiac Fibrosis and Remodeling

Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training

Open access
Benito, Begoña, Gay-Jordi, Gemma, Serrano-Mollar, Anna, Guasch, Eduard, Shi, Yanfen, Tardif, Jean-Claude, Brugada, Josep, Nattel, Stanley +1 more·2011·Circulation

Abstract

Background—: Recent clinical studies suggest that endurance sports may promote cardiac arrhythmias. The aim of this study was to use an animal model to evaluate whether sustained intensive exercise training induces potentially adverse myocardial remodeling and thus creates a potential substrate for arrhythmias. Methods and Results—: Male Wistar rats were conditioned to run vigorously for 4, 8, and 16 weeks; time-matched sedentary rats served as controls. Serial echocardiograms and in vivo electrophysiological studies at 16 weeks were obtained in both groups. After euthanasia, ventricular collagen deposition was quantified by histological and biochemical studies, and messenger RNA and protein expression of transforming growth factor-β1, fibronectin-1, matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-1, procollagen-I, and procollagen-III was evaluated in all 4 cardiac chambers. At 16 weeks, exercise rats developed eccentric hypertrophy and diastolic dysfunction, together with atrial dilation. In addition, collagen deposition in the right ventricle and messenger RNA and protein expression of fibrosis markers in both atria and right ventricle were significantly greater in exercise than in sedentary rats at 16 weeks. Ventricular tachycardia could be induced in 5 of 12 exercise rats (42%) and only 1 of 16 sedentary rats (6%; P =0.05). The fibrotic changes caused by 16 weeks of intensive exercise were reversed after an 8-week exercise cessation. Conclusions—: In this animal model, we documented cardiac fibrosis after long-term intensive exercise training, together with changes in ventricular function and increased arrhythmia inducibility. If our findings are confirmed in humans, the results would support the notion that long-term vigorous endurance exercise training may in some cases promote adverse remodeling and produce a substrate for cardiac arrhythmias.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.110.938282

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intense endurance exercise promoted RV-specific fibrosis in rats, which increased vulnerability to ventricular tachycardia following programmed stimulation.

    “Benito et al. 15 recently documented that intense endurance exercise promoted RV-specific fibrosis in rats which increased vulnerability to ventricular tachycardia following programmed stimulation.”

    From Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes (2012) · cites this paper as [15]

    The chamber-specific remodeling section reports right-ventricular fibrosis after intensive training, with no observed left-ventricular difference. The ventricular-arrhythmia section reports greater inducibility during programmed stimulation in exercise rats (42% versus 6%). But the discussion says fibrosis *could play a role* in that susceptibility; it does not establish that the fibrosis caused the increase. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Recent data suggest that exercise-induced proarrhythmic substrates may develop in the RV while sparing the LV.

    “Studies focussing on the LV of athletes have failed to provide these mechanistic insights, 4 but recent data have suggested that exercise-induced proarrhythmic substrates may develop in the RV while sparing the LV.12,13,15”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. Hu FB, Sigal RJ, Rich-Edwards JW, Colditz GA, Solomon CG, Willett WC, Speizer FE, Manson JE. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA. 1999;282:1433-1439.
  2. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ. Exercise and Heart failure: a statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention. Circulation. 2003;107: 1210 -1225.
  3. Fagard R. Athlete's heart. Br Heart J. 2003;89:1455-1461.
  4. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, Pisicchio C, Roselli A, Caselli S, Culasso F. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005; 46:690 -696.
  5. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311: 874 -877.
  6. Mont L, Sambola A, Brugada J, Vacca M, Marrugat J, Elosua R, Pare C, Azqueta M, Sanz G. Long-lasting sport practice and lone atrial fibril- lation. Eur Heart J. 2002;23:477-482.
  7. Elosua R, Arquer A, Mont L, Sambola A, Molina L, Garcia-Moran E, Brugada J, Marrugat J. Sport practice and the risk of lone atrial fibril- lation: a case-control study. Int J Cardiol. 2006;108:332-337.
  8. Baldesberger S, Bauersfeld U, Candinas R, Seifert B, Zuber M, Ritter M, Jenni R, Oechslin E, Luthi P, Scharf C, Marti B, Attenhofer Jost CH. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008;29:71-78.
  9. Ector J, Ganame J, van der Merwe N, Adriaenssens B, Pison L, Willems R, Gewillig M, Heidbuchel H. Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quanti- tative angiographic assessment. Eur Heart J. 2007;28:345-353.
  10. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802-809.
  11. Fenning A, Harrison G, Dwyer D, Rose'Meyer R, Brown L. Cardiac adaptation to endurance exercise in rats. Mol Cell Biochem. 2003;251: 51-59.
  12. Woodiwiss A, Oosthuyse T, Norton G. Reduced cardiac stiffness fol- lowing exercise is associated with preserved myocardial collagen char- acteristics in the rat. Eur J Appl Physiol Occup Physiol. 1998;78: 148 -154.
  13. Rocha FL, Carmo EC, Roque FR, Hashimoto NY, Rossoni LV, Frimm C, Aneas I, Negrao CE, Krieger JE, Oliveira EM. Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. Am J Physiol Heart Circ Physiol. 2007;293: H3575-H3583.
  14. Butt RP, Laurent GJ, Bishop JE. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur J Cell Biol. 1995;68:330 -335.
  15. Brooks WW, Conrad CH. Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice. J Mol Cell Cardiol. 2000;32:187-195.
  16. Tomita H, Egashira K, Ohara Y, Takemoto M, Koyanagi M, Katoh M, Yamamoto H, Tamaki K, Shimokawa H, Takeshita A. Early induction of transforming growth factor-beta via angiotensin II type 1 receptors con- tributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension. 1998;32:273-279.
  17. Norton GR, Tsotetsi J, Trifunovic B, Hartford C, Candy GP, Woodiwiss AJ. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hyper- tensive rats. Circulation. 1997;96:1991-1998.
  18. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114: 1633-1644.
  19. Lindsay MM, Dunn FG. Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Br J Sports Med. 2007;41:447-452.
  20. Selvetella G, Hirsch E, Notte A, Tarone G, Lembo G. Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc Res. 2004;63:373-380.
  21. O'Neill BT, Abel ED. Akt1 in the cardiovascular system: friend or foe? J Clin Invest. 2005;115:2059 -2064.
  22. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angio- genesis contributes to the transition to heart failure. J Clin Invest. 2005; 115:2108 -2118.
  23. vila-Roman VG, Guest TM, Tuteur PG, Rowe WJ, Ladenson JH, Jaffe AS. Transient right but not left ventricular dysfunction after strenuous exercise at high altitude. J Am Coll Cardiol. 1997;30:468 -473.
  24. Modesti PA, Vanni S, Bertolozzi I, Cecioni I, Lumachi C, Perna AM, Boddi M, Gensini GF. Different growth factor activation in the right and left ventricles in experimental volume overload. Hypertension. 2004;43: 101-108.
  25. Verheule S, Sato T, Everett T IV, Engle SK, Otten D, Rubart-von der Lohe M, Nakajima HO, Nakajima H, Field LJ, Olgin JE. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-␤1. Circ Res. 2004;94: 1458 -1465.
  26. Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L. Atrial extracellular matrix remodeling and the mainte- nance of atrial fibrillation. Circulation. 2004;109:363-68.
  27. Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley AJ III, Spinale FG, Gold MR. Selective induction of matrix metalloproteinases and tissue inhibitor of metallopro- teinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol. 2006;97:532-537.
  28. Blangy H, Sadoul N, Dousset B, Radauceanu A, Fay R, Aliot E, Zannad F. Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace. 2007;9:724 -729.
  29. Wisloff U, Helgerud J, Kemi OJ, Ellingsen O. Intensity-controlled treadmill running in rats: VO(2 max) and cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2001;280:H1301-H1310.
  30. Copp SW, Davis RT, Poole DC, Musch TI. Reproducibility of endurance capacity and VO 2 peak in male Sprague-Dawley rats. J Appl Physiol. 2009;106:1072-1078.
  31. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Asso- ciation. Circulation. 2001;104:1694 -1740.
  32. Faber MJ, Dalinghaus M, Lankhuizen IM, Steendijk P, Hop WC, Schoemaker RG, Duncker DJ, Lamers JM, Helbing WA. Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops. Am J Physiol Heart Circ Physiol. 2006;291:H1580 -H1586.
  33. SDS-PAGE and Western blot Protein samples were extracted using Nonidet P-40 buffer. SDS-PAGE was performed on 5%- 13% acrylamide gels. Proteins were electrotransferred to nitrocellulose membrane and probed with primary antibodies. The antibodies used included mouse monoclonal anti-TGF-β1 (ab27969, dilution1/2000), mouse monoclonal anti-MMP2 (ab7032 dilution 1/1000), rabbit polyclonal to TIMP1 (ab61224 dilution 1/1000), mouse monoclonal to collagen-I (ab6308 dilution 1/1000) (all of them acquired from Abcam plc, Cambridge, UK); rabbit polyclonal anti- fibronectin ( BP8025, dilution 1/1000) (Acris Antibodies GmbH, Herford, Germany) and rabbit polyclonal to collagen-III (dilution 1/500) (Santa Cruz Biotechnology, Ca, USA), and mouse monoclonal anti-actin (dilution (1/1000) (Chemicon-Millipore Co, MA, USA), which served as a housekeeping reference. The membranes were incubated with the corresponding peroxidase- conjugated secondary antibodies, washed, and then incubated with ECL reagents (GE Healthcare Europe GmbH; Freigburg; GE) before exposure to high performance by guest on June 24, 2013 http://circ.ahajournals.org/ Downloaded from SUPPLEMENTAL REFERENCES Reference List
  34. Reffelmann T, Kloner RA. Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Res Cardiol. 2003; 98:275-84.
  35. Shi Y, Denault AY, Couture P, Butnaru A, Carrier M, Tardif JC. Biventricular diastolic filling patterns after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2006; 131:1080- 6.
  36. Fulton RM, Hutchinson EC, Jones AM. Ventricular weight in cardiac hypertrophy. Br Heart J. 1952; 14:413-20.
  37. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979; 11:447-55.
  38. Woessner JFJ. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961; 93:440-7.

Cited by

Sorted by citations

Authors
Benito, B., Gay-Jordi, G., Serrano-Mollar, A., Guasch, E., Shi, Y., Tardif, J.-C., Brugada, J., Nattel, S., & Mont, L.
Affiliations
  • Montreal Heart Institute (CA)
  • From the Thorax Institute, Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain (B.B., E.G., J.B., L.M.); Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Catalonia, Spain (B.B., G.G.-J., A.S.-M., E.G., J.B., L.M.); Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada (B.B., Y.S., J.-C.T., S.N.); and Department of Experimental Pathology, Institut d'Investigacions Biomèdiques de Barcelona, Barcelona, Catalonia, Spain (G.G....
Venue
Circulation
Published
2011-01
Volume
123
Issue
1
Pages
13-22
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1974266173
Cited by
478
References
10
Citations by year
2026: 18 · 2025: 22 · 2024: 21 · 2023: 28 · 2022: 33 · 2021: 21 · 2020: 29 · 2019: 23 · 2018: 32 · 2017: 35 · 2016: 41 · 2015: 42 · 2014: 41 · 2013: 35 · 2012: 33
FWCI
19.77
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
Funders
  • Sociedad Española de Cardiología
  • Fondation Leducq
  • Canadian Institutes of Health Research (MGP6957)
  • Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
cardiac arrhythmias, exercise-induced cardiac remodeling, endurance training, myocardial fibrosis, ventricular tachycardia, eccentric hypertrophy, diastolic dysfunction, atrial dilatation, collagen deposition, exercise cessation, fibrosis biomarkers, rat model
MeSH terms
Animals, Arrhythmias, Cardiac, Male, Physical Conditioning, Animal, Physical Endurance, Random Allocation, Time Factors, Rats, Wistar, Ventricular Remodeling, Models, Animal, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review